This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obama Administration Delivers A Trojan Horse Of Disrespect To Faith-Based Groups

New HHS Mandate Proposal Still Requires Morally Objectionable Insurance Coverage

DALLAS, Feb. 4, 2013 /PRNewswire-USNewswire/ -- Liberty Institute issued the following statement about the Obama Administration's new proposed rule regarding the HHS Mandate:

(Logo: http://photos.prnewswire.com/prnh/20120523/DC12743LOGO-b)

"The new proposed HHS rule is merely a Trojan Horse that misleads faith-based groups and all Americans into believing they will no longer have to provide objectionable insurance for birth control and abortion-inducing drugs," said Kelly Shackelford, Liberty Institute President and CEO.

"The Obama Administration has resorted to political-maneuvering as usual when it could have exempted all Americans who have a religious objection to the HHS mandate. In delivering this so-called compromise, the President disrespects the religious liberty rights of Christian colleges and other para-church ministries, while continuing to require faith-based businesses and individuals to provide and pay for insurance coverage to which they have religious objections."

About Liberty InstituteLiberty Institute is a nonprofit legal group dedicated to restoring and defending religious liberty across America – in our schools, for our churches, and throughout the public arena. Liberty Institute's vision is to reestablish liberty in accordance with the principles of our nation's founders. Visit www.LibertyInstitute.org for more information.

SOURCE Liberty Institute
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs